LGR5's Role in Colorectal Cancer
Author Information
Author(s): Francesca Walker, Hui-Hua Zhang, Annalisa Odorizzi, Antony W. Burgess, Pierre-Antoine Defossez
Primary Institution: Epithelial Biochemistry Laboratory, Ludwig Institute for Cancer Research, Parkville, Victoria, Australia
Hypothesis
LGR5 modulates Wnt responses and epithelial-mesenchymal transition (EMT) in colorectal cancer cell lines.
Conclusion
LGR5 acts as a negative regulator of tumorigenicity and enhances cell adhesion in colorectal cancer cells.
Supporting Evidence
- Ablation of LGR5 increases invasion and tumorigenicity in colorectal cancer cell lines.
- Overexpression of LGR5 reduces clonogenicity and enhances cell adhesion.
- LGR5 knockdown leads to increased expression of EMT-related genes.
Takeaway
LGR5 is a protein that helps keep cancer cells in their place, and when it's not there, the cancer cells can spread more easily.
Methodology
The study used RNA interference and overexpression techniques in colorectal cancer cell lines to assess the effects of LGR5 modulation on tumorigenicity and cell adhesion.
Limitations
The study primarily used cell lines, which may not fully replicate the complexity of in vivo tumor environments.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website